Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,464
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 301–350 of 581 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07276360	Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda(HypoRTCx-UG)	recruiting	Phase 2	278	Uganda Cancer InstituteOTHER	1	Mar 27, 2026	clinicaltrials
NCT07497074	JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer	not yet recruiting	Phase 2	78	Jiangsu Alphamab Biopharmaceuticals Co., LtdINDUSTRY	1	Mar 27, 2026